BioSpace News Archive

Basilea Pharmaceutica Ltd. announced that it has been awarded a grant of up to USD 2.7 million from CARB-X, a global partnership dedicated to supporting the early development of antibacterial products to diagnose, prevent and treat drug-resistant infections.

The Anterior cervical plating market is forecast to expand at healthy pace throughout the period 2021-2031.

Photocure ASA, the Bladder Cancer Company, reported Hexvix®/Cysview® revenues of NOK 81.6 million in the first quarter of 2021, and EBITDA of NOK 18.1 million, following the continued successful launch in markets previously operated by Ipsen Pharma SAS.

International medical imaging IT and cybersecurity company Sectra will install its solution for digital pathology at Institut Curie, one of the most recognized and prestigious cancer centers in France.

Ninth GPCR-targeted drug candidate overall generated from Sosei Heptares’ StaR® technology/SBDD platform to enter clinical development

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that the Company’s country leads for three key European markets are in place.

Dr. Brownstein, an esteemed epidemiologist, researcher at Boston Children’s Hospital and professor at Harvard Medical School, will assist on MINDCURE’s digital technology, data optimization and patient data security within iSTRYM, its psychedelic digital therapeutics platform

Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance

Burning Rock Biotech Limited announced the launch of the PRESCIENT study, the first blood-based, pan-cancer early-detection study in China using a multi-omics approach.

Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced that management will participate in the Oppenheimer MedTech, Tools, & Diagnostics Summit, May 26, 2021. Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, will provide a pre-recorded investor presentation